Healthcare ITNews

Healthcare AI Acquisition Corp. Announces That Its Class A Ordinary Shares And Warrants Will Be Traded Separately Beginning January 31, 2022.

Spread the love

Healthcare AI Acquisition

Three ways AI will change healthcare in the next decade - PMLiVE

Healthcare AI Acquisition Corp. (the “Company“), announced today that, commencing January 31, 2022, holders of the units sold in the Company’s public offering of 21,562,401 units, completed on December 14, 2021, which included the sale of additional 1,562,401 units in connection with the partial exercise of the underwriters’ option to purchase up to 3,000,000 units at the initial public offering price to cover over-allotments, may elect to separately trade the Class A ordinary shares and warrants included in the units. Those units not separated will continue to trade on the Nasdaq Stock Market LLC under the symbol “HAIAU,” and the Class A ordinary shares and warrants that are separated will trade on the NASDAQ under the symbols “HAIA” and “HAIAW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into Class A ordinary shares and warrants.

Recommended Articles:-https://prgazette.com/health/baby-food/

The units were initially offered by the Company in an underwritten offering. Citigroup Global Markets Inc. and Jefferies LLC acted as joint book-running managers for the offering.

The registration statement relating to the securities of the Company was declared effective by the U.S. Securities and Exchange Commission (the “SEC“) on December 9, 2021. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering was made only by means of a prospectus. Copies of the prospectus related to the offering may be obtained for free by visiting EDGAR on the SEC’s website  or by contacting Citigroup Global Markets Inc.

3 Ways HIT Impacts the Digital Healthcare Revolution

The Company is a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company is sponsored by Healthcare AI Acquisition, LLC, an affiliate of Stanley Capital. While the Company may pursue an initial business combination target in any industry or geographic region, it intends to focus its search on businesses in the healthcare and pharmaceutical industry, specifically companies within the e-Clinical, Healthcare Information Technology or Outsourced Pharmaceutical Services industries with high AI readiness and technological transformation potential.

 

Recommended Articles:- https://prgazette.com/news/cosmeceuticals/


Spread the love

Mark Ott

Mark is a graduate in sciences that are instrumental using an MBA in operations. He's also worked as a research partner for five decades, accompanying medical investigation. As a youth, he donated medical information to neighborhood college journals. His passion is researching and composing medical stories. He knows his stuff, and viewers love his sensible insights.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button